Assessment of setup uncertainties for various tumor sites when using daily CBCT for more than 2200 VMAT treatments.
The aim of this study was assess the patient setup errors for various tumor sites based on clinical data from a sufficient number of treatments with volumetric-modulated arc therapy (VMAT) using daily pretreatment CBCT imaging guidance. In addition, we calculated and compared the planning target volume (PTV) margins for all disease sites based on an analysis of specific systematic and random errors in our institution. All patients underwent pretreatment kV-CBCT imaging. The various tumor sites were divided into four categories; 21 brain (438 fractions), 35 head-and-neck tumors (H&amp;N, 933 fractions), 19 thorax and abdomen tumors (T&amp;A, 313 fractions), and 17 prostate cancer tumors (546 fractions). Overall distributions of setup corrections in all directions, frequencies of 3D vector lengths, institution-specific setup error, and PTV margins were analyzed. The longitudinal distribution for the T&amp;A site represented an asymmetric offset in the negative direction. Rotational distributions were comparable for all treatment sites, and the prostate site had the narrowest distribution of ≤ ± 2°. The cumulative frequencies of 3D vector length of ≥ 7 mm were rare for brain lesions and H&amp;N, but more common for T&amp;A and prostate lesions at 25.6% and 12.1%, respectively. The overall mean error for all treatment sites were within ± 1 mm and ± 0.1°, with the exception of the T&amp;A site, which had overall mean error of 2 mm in the negative longitudinal direction. The largest magnitude of systematic error and random error for the brain lesions and H&amp;N was 1.4 mm in the translational directions, and 3.3 mm for T&amp;A and prostate lesions. The PTV margins required in this analysis are ≤ 4 mm for the brain lesions and H&amp;N in all translational directions, but ranged from 4 to 10 mm for T&amp;A and prostate lesions. Analysis of each institution's specific setup errors using daily CBCT is essential for determining PTV margins and reducing setup uncertainties, because setup errors vary according to each immobilization system and patient.
Keimyung University Dongsan Medical Center. ykoh@dsmc.or.kr.
Young-Kee
YK
Oh
Jong-Geun
JG
Baek
Ok-Bae
OB
Kim
Jin-Hee
JH
Kim
D001932:Brain Neoplasms / Q000532:radiotherapy; D054893:Cone-Beam Computed Tomography / Q000379:methods*; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D007103:Immobilization; D008297:Male; D009369:Neoplasms / Q000532:radiotherapy*; D056888:Patient Positioning / Q000379:methods; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D061106:Radiotherapy Setup Errors; D061089:Radiotherapy, Image-Guided / Q000379:methods*; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*; D015203:Reproducibility of Results